Skip to main content

Epidemiology and Molecular Epidemiology.

Publication ,  Chapter
Bauchet, L; Ostrom, QT
January 2019

Incidence, prevalence, and survival for diffuse low-grade gliomas and diffuse anaplastic gliomas (including grade II and grade III astrocytomas and oligodendrogliomas) varies by histologic type, age at diagnosis, sex, and race/ethnicity. Significant progress has been made in identifying potential risk factors for glioma, although more research is warranted. The strongest risk factors that have been identified thus far include allergies/atopic disease, ionizing radiation, and heritable genetic factors. Further analysis of large, multicenter epidemiologic studies, and well-annotated "omic" datasets, can potentially lead to further understanding of the relationship between gene and environment in the process of brain tumor development.

Duke Scholars

DOI

Publication Date

January 2019

Volume

30

Start / End Page

1 / 16

Related Subject Headings

  • Oligodendroglioma
  • Neurology & Neurosurgery
  • Mutation
  • Molecular Epidemiology
  • Humans
  • Glioma
  • Brain Neoplasms
  • Astrocytoma
  • Animals
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Bauchet, L., & Ostrom, Q. T. (2019). Epidemiology and Molecular Epidemiology. (Vol. 30, pp. 1–16). https://doi.org/10.1016/j.nec.2018.08.010
Bauchet, Luc, and Quinn T. Ostrom. “Epidemiology and Molecular Epidemiology.,” 30:1–16, 2019. https://doi.org/10.1016/j.nec.2018.08.010.
Bauchet L, Ostrom QT. Epidemiology and Molecular Epidemiology. In 2019. p. 1–16.
Bauchet, Luc, and Quinn T. Ostrom. Epidemiology and Molecular Epidemiology. Vol. 30, 2019, pp. 1–16. Pubmed, doi:10.1016/j.nec.2018.08.010.
Bauchet L, Ostrom QT. Epidemiology and Molecular Epidemiology. 2019. p. 1–16.

DOI

Publication Date

January 2019

Volume

30

Start / End Page

1 / 16

Related Subject Headings

  • Oligodendroglioma
  • Neurology & Neurosurgery
  • Mutation
  • Molecular Epidemiology
  • Humans
  • Glioma
  • Brain Neoplasms
  • Astrocytoma
  • Animals